Fuel Cell Hybrid Commercial Vehicle (FCHCV)
Fuel Cell Hybrid Commercial Vehicle (FCHCV)
批准号:
133618
负责人:
金额:
$21.95万
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
"Vehicle emission regulations and government policy are becoming more stringent. In terms of regulations, Euro 6 has been active for light passenger and commercial vehicles since 2014 and OEMs need to meet 95g/km CO2 target by 2020\. Since diesel scandal in 2015, government and council restrict petrol vehicles in 2030 to 2040\. In order to meet new emission regulations and social requirement, OEMs realize conventional technology is not enough and heavily invest in electrified powertrains.Commercial vehicle sector follows same electrification way as passenger car sector. Heavy-duty vehicles are soon expected to come under severe CO2 regulation in Europe as the sector's CO2 target are announced in 2018\. Tesla has announced its plan to develop pure electric truck by 2019 and other conventional OEMs, Daimler and Caterpillar, are working on an electric commercial vehicle. Renault introduces electric van, Kangoo Z.E since 2011\.Having said that, there is still bottleneck of BEV penetration: short driving range and charging time. It is more critical for commercial vehicles since for longer driving range the more battery capacity is necessary, which needs more charging time. Fuel cell technology could mitigate this problem with relatively high energy density compared to the battery. In this project, the two powertrain concepts (FCREx and FCHEV) and fuel cell types (PEMFCand DMFC) are further combined with three different commercial vehicle types -- vans, buses, and trucks. From this project, OEMs can find appropriate system architecture and fuel cell type for different vehicle type and optimize the components sizing and controller while meeting commercial vehicle requirement. The project outcomes not only help OEMs to understand whether they can meet CO2 emission target but also help the government to predict whether they can meet emission target in the city."
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
面向Cell-Free网络的协同虚拟化与动态传输
-
批准号:62371367
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈健
-
依托单位:
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
-
批准号:82373069
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:何美芳
-
依托单位:
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:宋贾俊
-
依托单位:
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
-
批准号:82273886
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:原永芳
-
依托单位:
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2022
-
负责人:黄红艳
-
依托单位:
外泌体ORM1作为肿瘤免疫微环境中T细胞耗竭(T Cell Exhaustion)生物标志物及其功能研究
-
批准号:82102500
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:杨阳
-
依托单位: